| Literature DB >> 26004160 |
Tetsuya Akaishi1, Ichiro Nakashima1, Tatsuro Misu2, Kazuo Fujihara2, Masashi Aoki1.
Abstract
Depression and chronic fatigue are frequently present in multiple sclerosis (MS); however, the prevalence rates have not been investigated in neuromyelitis optica (NMO). Thirty-nine consecutive NMO and 75 MS patients were compared using self-rating questionnaires for depressive states, daily activity, and fatigue, as well as serum carnitine levels. A subgroup of patients with low carnitine levels were re-evaluated regarding depression and fatigue after levocarnitine treatment. Depression and fatigue were equally prevalent in MS and NMO and were strongly correlated with one another. Measurement of the serum carnitine levels and the administration of levocarnitine did not appear to be beneficial.Entities:
Keywords: Carnitine; Depression; Fatigue; Levocarnitine; Neuromyelitis optica
Mesh:
Substances:
Year: 2015 PMID: 26004160 DOI: 10.1016/j.jneuroim.2015.05.007
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478